BDSI logo

BioDelivery Sciences International (BDSI) Cash From Operations

Annual CFO

$41.04 M
+$16.06 M+64.27%

31 December 2021

BDSI Cash From Operations Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CFO

$13.75 M
+$6.79 M+97.47%

31 December 2021

BDSI Quarterly CFO Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CFO

$41.04 M
+$2.73 M+7.13%

31 December 2021

BDSI TTM CFO Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BDSI Cash From Operations Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years+64.3%+97.5%+7.1%
5 y5 years+270.2%+1032.1%+451.1%

BDSI Cash From Operations High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall timeat high-52.6%at high

BioDelivery Sciences International Cash From Operations History

DateAnnualQuarterlyTTM
Dec 2021
$41.04 M(+64.3%)
$13.75 M(+97.5%)
$41.04 M(+7.1%)
Sept 2021
-
$6.96 M(-24.6%)
$38.30 M(-5.0%)
June 2021
-
$9.23 M(-16.8%)
$40.32 M(+35.8%)
Mar 2021
-
$11.10 M(+0.7%)
$29.69 M(+18.9%)
Dec 2020
$24.98 M(+125.6%)
$11.02 M(+22.7%)
$24.98 M(-19.1%)
Sept 2020
-
$8.98 M(-742.1%)
$30.89 M(+51.1%)
June 2020
-
-$1.40 M(-121.9%)
$20.43 M(+0.4%)
Mar 2020
-
$6.39 M(-62.3%)
$20.34 M(+83.8%)
Dec 2019
$11.07 M(-145.9%)
$16.92 M(-1247.2%)
$11.07 M(-194.7%)
Sept 2019
-
-$1.48 M(-0.9%)
-$11.69 M(-30.2%)
June 2019
-
-$1.49 M(-48.4%)
-$16.74 M(-17.3%)
Mar 2019
-
-$2.89 M(-50.6%)
-$20.24 M(-16.1%)
Dec 2018
-$24.11 M(-25.7%)
-$5.84 M(-10.6%)
-$24.11 M(-19.2%)
Sept 2018
-
-$6.53 M(+31.0%)
-$29.84 M(+8.6%)
June 2018
-
-$4.98 M(-26.3%)
-$27.48 M(-9.0%)
Mar 2018
-
-$6.76 M(-41.6%)
-$30.21 M(-6.9%)
Dec 2017
-$32.45 M(-39.9%)
-$11.57 M(+177.5%)
-$32.45 M(-3.1%)
Sept 2017
-
-$4.17 M(-45.9%)
-$33.50 M(-20.5%)
June 2017
-
-$7.71 M(-14.4%)
-$42.12 M(-9.1%)
Mar 2017
-
-$9.00 M(-28.7%)
-$46.33 M(-14.2%)
Dec 2016
-$53.98 M(+1346.5%)
-$12.62 M(-1.3%)
-$53.98 M(+336.3%)
Sept 2016
-
-$12.79 M(+7.3%)
-$12.37 M(-4.5%)
June 2016
-
-$11.91 M(-28.5%)
-$12.95 M(-15.8%)
Mar 2016
-
-$16.66 M(-157.5%)
-$15.38 M(+312.2%)
Dec 2015
-$3.73 M(-87.1%)
$28.98 M(-316.8%)
-$3.73 M(-92.6%)
Sept 2015
-
-$13.37 M(-6.8%)
-$50.75 M(+28.7%)
June 2015
-
-$14.35 M(+186.6%)
-$39.45 M(+14.5%)
Mar 2015
-
-$5.00 M(-72.2%)
-$34.45 M(+19.5%)
Dec 2014
-$28.83 M(-52.0%)
-$18.03 M(+775.0%)
-$28.83 M(+11.1%)
Sept 2014
-
-$2.06 M(-78.0%)
-$25.96 M(-39.7%)
June 2014
-
-$9.35 M(-1630.1%)
-$43.07 M(-6.3%)
Mar 2014
-
$611.00 K(-104.0%)
-$45.97 M(-23.5%)
Dec 2013
-$60.10 M(-593.2%)
-$15.16 M(-20.9%)
-$60.10 M(+14.7%)
Sept 2013
-
-$19.17 M(+56.6%)
-$52.40 M(+12.6%)
June 2013
-
-$12.24 M(-9.5%)
-$46.53 M(+95.2%)
Mar 2013
-
-$13.52 M(+81.2%)
-$23.84 M(-295.6%)
Dec 2012
$12.19 M(-152.4%)
-$7.46 M(-43.9%)
$12.19 M(-20.3%)
Sept 2012
-
-$13.30 M(-227.3%)
$15.30 M(-32.4%)
June 2012
-
$10.45 M(-53.5%)
$22.62 M(+321.7%)
Mar 2012
-
$22.50 M(-617.2%)
$5.36 M(-123.1%)
Dec 2011
-$23.27 M
-$4.35 M(-27.2%)
-$23.27 M(+2.2%)
Sept 2011
-
-$5.98 M(-12.1%)
-$22.77 M(+15.6%)
June 2011
-
-$6.80 M(+10.8%)
-$19.69 M(+45.3%)
DateAnnualQuarterlyTTM
Mar 2011
-
-$6.14 M(+59.7%)
-$13.56 M(+16.0%)
Dec 2010
-$11.68 M(-164.2%)
-$3.84 M(+32.5%)
-$11.68 M(-1.9%)
Sept 2010
-
-$2.90 M(+333.4%)
-$11.91 M(-189.0%)
June 2010
-
-$669.60 K(-84.3%)
$13.38 M(+10.8%)
Mar 2010
-
-$4.27 M(+4.8%)
$12.07 M(-33.7%)
Dec 2009
$18.19 M(-285.3%)
-$4.07 M(-118.2%)
$18.19 M(-14.4%)
Sept 2009
-
$22.38 M(-1231.9%)
$21.24 M(-589.6%)
June 2009
-
-$1.98 M(-206.6%)
-$4.34 M(-17.9%)
Mar 2009
-
$1.86 M(-282.6%)
-$5.29 M(-46.1%)
Dec 2008
-$9.82 M(-180.3%)
-$1.02 M(-68.3%)
-$9.82 M(-32.6%)
Sept 2008
-
-$3.20 M(+9.4%)
-$14.57 M(-199.1%)
June 2008
-
-$2.93 M(+9.4%)
$14.70 M(+25.6%)
Mar 2008
-
-$2.67 M(-53.7%)
$11.70 M(-4.2%)
Dec 2007
$12.22 M(-226.2%)
-$5.77 M(-122.1%)
$12.22 M(-22.8%)
Sept 2007
-
$26.07 M(-540.0%)
$15.83 M(-245.8%)
June 2007
-
-$5.93 M(+174.4%)
-$10.85 M(+27.7%)
Mar 2007
-
-$2.16 M(+0.1%)
-$8.50 M(-12.2%)
Dec 2006
-$9.68 M(+25.6%)
-$2.16 M(+253.7%)
-$9.68 M(-7.9%)
Sept 2006
-
-$610.20 K(-82.9%)
-$10.52 M(-7.8%)
June 2006
-
-$3.57 M(+6.8%)
-$11.40 M(+23.3%)
Mar 2006
-
-$3.34 M(+11.6%)
-$9.25 M(+19.9%)
Dec 2005
-$7.71 M(+163.0%)
-$2.99 M(+100.2%)
-$7.71 M(+33.2%)
Sept 2005
-
-$1.50 M(+5.6%)
-$5.79 M(+35.0%)
June 2005
-
-$1.42 M(-21.5%)
-$4.29 M(+16.1%)
Mar 2005
-
-$1.80 M(+68.6%)
-$3.69 M(+25.9%)
Dec 2004
-$2.93 M(+21.0%)
-$1.07 M(<-9900.0%)
-$2.93 M(+2.8%)
Sept 2004
-
$6200.00(-100.8%)
-$2.85 M(-31.4%)
June 2004
-
-$822.70 K(-21.3%)
-$4.16 M(-7.2%)
Mar 2004
-
-$1.04 M(+5.4%)
-$4.48 M(+84.9%)
Dec 2003
-$2.42 M(-3.6%)
-$991.40 K(-23.5%)
-$2.42 M(+26.2%)
Sept 2003
-
-$1.30 M(+13.1%)
-$1.92 M(-5.5%)
June 2003
-
-$1.15 M(-213.3%)
-$2.03 M(+77.3%)
Mar 2003
-
$1.01 M(-306.8%)
-$1.15 M(-54.4%)
Dec 2002
-$2.51 M(+54.1%)
-$489.10 K(-65.3%)
-$2.51 M(+16.2%)
Sept 2002
-
-$1.41 M(+440.7%)
-$2.16 M(+99.5%)
June 2002
-
-$260.50 K(-27.0%)
-$1.08 M(-29.2%)
Mar 2002
-
-$356.70 K(+158.3%)
-$1.53 M(-6.1%)
Dec 2001
-$1.63 M(+463.6%)
-$138.10 K(-58.1%)
-$1.63 M(+9.2%)
Sept 2001
-
-$329.50 K(-53.5%)
-$1.49 M(+28.3%)
June 2001
-
-$708.30 K(+55.5%)
-$1.16 M(+155.5%)
Mar 2001
-
-$455.60 K(<-9900.0%)
-$455.60 K(<-9900.0%)
Dec 2000
-$289.50 K
-
-
Mar 2000
-
$0.00
$0.00

FAQ

  • What is BioDelivery Sciences International annual cash flow from operations?
  • What is the all time high annual CFO for BioDelivery Sciences International?
  • What is BioDelivery Sciences International quarterly cash flow from operations?
  • What is the all time high quarterly CFO for BioDelivery Sciences International?
  • What is BioDelivery Sciences International TTM cash flow from operations?
  • What is the all time high TTM CFO for BioDelivery Sciences International?

What is BioDelivery Sciences International annual cash flow from operations?

The current annual CFO of BDSI is $41.04 M

What is the all time high annual CFO for BioDelivery Sciences International?

BioDelivery Sciences International all-time high annual cash flow from operations is $41.04 M

What is BioDelivery Sciences International quarterly cash flow from operations?

The current quarterly CFO of BDSI is $13.75 M

What is the all time high quarterly CFO for BioDelivery Sciences International?

BioDelivery Sciences International all-time high quarterly cash flow from operations is $28.98 M

What is BioDelivery Sciences International TTM cash flow from operations?

The current TTM CFO of BDSI is $41.04 M

What is the all time high TTM CFO for BioDelivery Sciences International?

BioDelivery Sciences International all-time high TTM cash flow from operations is $41.04 M